Suchergebnisse

Assurant, Inc. AIZ shares are trading at a discount compared with the Zacks Multi-line Insurance industry. Its forward price-to-book value of 1.9X is lower than the industry average of 2.25X, the Fi

Merck MRK continues to face challenges with its second-largest product, Gardasil, which is a vaccine approved to prevent certain cancers caused by the human papillomavirus. While the vaccine’s sales

Roche RHHBY announced results from a late-stage study evaluating its investigational candidate, giredestrant, in combination with palbociclib for patients with estrogen receptor (ER)-positive, human

Canadian Natural Resources Limited CNQ reported fourth-quarter 2025 adjusted earnings per share of 59 cents, which beat the Zacks Consensus Estimate of 53 cents. However, the bottom line decreased

Last month, Old Dominion Freight Line, Inc. (ODFL) stated that its board of directors had announced an increase in its quarterly dividend payout, reflectingthe company’s commitment to boosting

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.09 per share a year ago. These figures are adjusted

Custom Truck One Source, Inc. (CTOS) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago. These

Exagen Inc. (XGN) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.2 per share a year ago. These figures are adjusted for

Petroleo Brasileiro S.A., or Petrobras PBR, posted fourth-quarter earnings per ADS of 72 cents, beating the Zacks Consensus Estimate of 57 cents. The bottom line improved from the year-ago profit of

Investors interested in stocks from the Insurance - Multi line sector have probably already heard of Aegon NV (AEG) and Prudential (PUK). But which of these two stocks presents investors with the

GSK plc GSK signed a license agreement with Italy-based Alfasigma. Per the terms of the agreement, Alfasigma has acquired exclusive global rights from GSK to develop and market linerixibat, an

Shares of Xenon Pharmaceuticals XENE surged 49.6% yesterday after the company announced positive top-line data from the phase III X-TOLE2 study, which evaluated its lead pipeline candidate

Booz Allen Hamilton’s BAH top line is gaining from long-term government contracts, providing steady revenues and offsetting market volatility. The company’s strong strategies improve operational

Vail Resorts, Inc. MTN reported dismal second-quarter fiscal 2026 results, with earnings and revenues missing the Zacks Consensus Estimate. On a year-over-year basis, both the top and bottom lines

Groupon (GRPN) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $1.2 per share a year ago. These figures are adjusted for

Denison Mine (DNN) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.02 per share a year ago. These figures are adjusted for

Groupon GRPN posted earnings of 17 cents per share for the fourth quarter of 2025, in line with the Zacks Consensus Estimate. The company had reported a loss of $1.2 per share in the year-ago

Franco-Nevada Corporation FNV reported adjusted earnings of $1.85 per share in fourth-quarter 2025, beating the Zacks Consensus Estimate of $1.68. The bottom line increased 95% year over year.

Dollar Tree, Inc. DLTR is likely to register a decline in its top line when it reports fourth-quarter fiscal 2025 results on March 16, before market open. The Zacks Consensus Estimate for revenues

This morning, pre-markets are remaining volatile but dancing around a zero balance — both before and after the latest Consumer Price Index (CPI) report for February, which came in as expected